Comparative Effectiveness of Sodium-Glucose Co-transporter 2 Inhibitors and Thiazolidinediones in Reducing Adverse Cardiovascular Events in Type 2 Diabetes. [PDF]
Ali A +5 more
europepmc +1 more source
Reply to correspondence on “Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: a network meta-analysis” [PDF]
Tian-Yi Ren +2 more
doaj +1 more source
Long-Term Glucagon-Like Peptide 1 Receptor Agonist Use Is Not Associated With Increased Risk of Thyroid Cancer in Adults With Type 2 Diabetes. [PDF]
Pollack R, Stokar J.
europepmc +1 more source
Effects of dietary supplementation of pioglitazone on metabolism, milk yield and reproductive performance in transition dairy cows [PDF]
Fouladi-Nashta, A A +4 more
core +1 more source
Case Report: Generalized lipodystrophy following immune-checkpoint inhibitor therapy. [PDF]
Lee AH, Hui R, Gunton JE.
europepmc +1 more source
Caution in handling switchers in pharmacoepidemiologic studies estimating treatment effects: the example of dipeptidyl peptidase-4 inhibitors and inflammatory bowel disease. [PDF]
Wang T +15 more
europepmc +1 more source
Effects of Brown Rice, Meal Replacements, and Anti-Obesity Drugs on Mitochondria in Obese Rats. [PDF]
Handayani D +5 more
europepmc +1 more source
Medications to reduce breast cancer risk: a network meta-analysis of randomized controlled trials. [PDF]
Pourali G +5 more
europepmc +1 more source
Evolving trends of antidiabetic agents stratified by age, kidney function and body mass index: Insights from a nationwide claims database. [PDF]
Aoyama K +14 more
europepmc +1 more source
Pharmacotherapy agents in prevention and treatment of breast cancer-related lymphedema: a systematic scoping review. [PDF]
Lommer C +12 more
europepmc +1 more source

